Liberty Biopharma (LTY) Stock Price, News & Analysis

Company Overview

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Key Stats

• Today's Range: C$2.00 to C$2.00
• 50-Day Range: C$2.00 to C$2.00
• 52-Week Range: C$0.06 to C$2.74
• Volume: 700 shs
• Average Volume: 23,286 shs
• Market Capitalization: C$21.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: CVE:LTY
• Previous Symbol: CVE:VVA
• CIK: N/A
• Web: www.libertybiopharma.com
• Phone: +1-604-3777575
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 8.19
• Current Ratio: 0.12
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 2,000.00
• Book Value: C$0.79 per share
• Price / Book: 2.53

Miscellaneous

• Outstanding Shares: 10,770,000
• Free Float: N/A
• Market Cap: C$21.54 million
• Optionable: Not Optionable
• Beta: N/A